Health
Drug May Reduce Tumor Volume in Neurofibromatosis – Technology Networks
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume…
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1). The results of the Phase 2 clinical trial, co-chaired by Michael J. Fisher, MD at CHOP, were published recently in Nature Medicine.
“This is the second…
-
Business10 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Noosa News23 hours agoBasic cyber steps can block most attacks – Proctor
-
Noosa News18 hours agoWhat instrument did Japan’s heavy-metal PM play? Take the Brisbane Times Quiz
-
Noosa News21 hours agoFamily ‘quite nasty’ to woman who married step-uncle before his alleged murder, court hears